CD19 and acute lymphoblastic leukemia: A correlation between biomarkers indicative of endothelial dysfunction and the severity of CRS was identified after evaluation of a cohort of 133 adult patients with R/R B-ALL, CLL, or NHL who received LD followed by infusion of anti-CD19 CAR-T cells [49].